Drug design, development and therapy

Keyphrases

Publications

volume 17, 2023

Yuqi Liang, Guosong Wu, Tianyu Luo, Haimei Xie, Qian Zuo, Ping Huang, Huachao Li, Liushan Chen, Hai Lu, Qianjun Chen
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling. Drug design, development and therapy 17 (2023)
Yuqi Liang, Guosong Wu, Tianyu Luo, Haimei Xie, Qian Zuo, Ping Huang, Huachao Li, Liushan Chen, Hai Lu, Qianjun Chen
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling. Drug design, development and therapy 17 (2023)
Shuya Zhao, Yunyang Zhang, Yun Chen, Xianghui Xing, Yu Wang, Guofeng Wu
Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding. Drug design, development and therapy 17 (2023)
Yalan Huang, Yanling Zhang, Yongjun Wu, Qin Xiang, Rong Yu
An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy. Drug design, development and therapy 17 (2023)
Huifeng Di, Hui Liu, Shuna Xu, Na Yi, Guangchen Wei
Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Jin-Jin Yang, Lei Lei, Di Qiu, Sai Chen, Li-Ka Xing, Jing-Wei Zhao, Yuan-Yuan Mao, Jian-Jun Yang
Effect of Remimazolam on Postoperative Delirium in Older Adult Patients Undergoing Orthopedic Surgery: A Prospective Randomized Controlled Clinical Trial. Drug design, development and therapy 17 (2023)
Yuqi Liang, Guosong Wu, Tianyu Luo, Haimei Xie, Qian Zuo, Ping Huang, Huachao Li, Liushan Chen, Hai Lu, Qianjun Chen
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling. Drug design, development and therapy 17 (2023)
Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Huifeng Di, Hui Liu, Shuna Xu, Na Yi, Guangchen Wei
Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne. Drug design, development and therapy 17 (2023)
Sara Horst, Raymond K Cross
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported Outcomes. Drug design, development and therapy 17 (2023)
Jianhong Zhang, Xinhui Wu, Baiyin Zhong, Qicheng Liao, Xin Wang, Yuankang Xie, Xiao He
Review on the Diverse Biological Effects of Glabridin. Drug design, development and therapy 17 (2023)
Muhammad Anwar Bashir, Amjad Khan, Sayyed Ibrahim Shah, Majeed Ullah, Fazli Khuda, Muhammad Abbas, Khang Wen Goh, Long Chiau Ming
Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug. Drug design, development and therapy 17 (2023)
Wenming Zhao, Chengwei Yang, Ning Zhang, Yuanyuan Peng, Ying Ma, Keru Gu, Xia Liu, Xiaohui Liu, Xijian Liu, Yumin Liu, Songkai Li, Linjing Zhao
Menthone Exerts its Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus by Affecting Cell Membrane Properties and Lipid Profile. Drug design, development and therapy 17 (2023)
Tommy Tsang Cheung, Tu H Mai, Yen Lin Chia, Desmond Y H Yap, Chi-Ho Lee, Cecil Chi-Keung Chen, Ying Huang, Yuwen Jin, James Johnston, Viktoria Werkström, Yuhui Yao, Xiaoyun Ge, Wenying Zheng
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants. Drug design, development and therapy 17 (2023)
Shuya Zhao, Yunyang Zhang, Yun Chen, Xianghui Xing, Yu Wang, Guofeng Wu
Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
Wenming Zhao, Chengwei Yang, Ning Zhang, Yuanyuan Peng, Ying Ma, Keru Gu, Xia Liu, Xiaohui Liu, Xijian Liu, Yumin Liu, Songkai Li, Linjing Zhao
Menthone Exerts its Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus by Affecting Cell Membrane Properties and Lipid Profile. Drug design, development and therapy 17 (2023)
Qianwen Guo, Xue Li, Wenbin Li, Rong Wang, Anpeng Zhao, Zihan Wang
A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude. Drug design, development and therapy 17 (2023)
Shih-Lung Cheng, Ping-Huai Wang, Cheng-Yu Chang, Hsu-Hui Wang, Chung-Jen Wang, Kuan-Ming Chiu
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19. Drug design, development and therapy 17 (2023)
Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Zuoya Sun, Zhiyuan Chen, Ruihong Liu, Gang Lu, Zhuo Li, Yi Sun
Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients. Drug design, development and therapy 17 (2023)
Jianhong Zhang, Xinhui Wu, Baiyin Zhong, Qicheng Liao, Xin Wang, Yuankang Xie, Xiao He
Review on the Diverse Biological Effects of Glabridin. Drug design, development and therapy 17 (2023)
Huifeng Di, Hui Liu, Shuna Xu, Na Yi, Guangchen Wei
Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne. Drug design, development and therapy 17 (2023)
Sara Horst, Raymond K Cross
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported Outcomes. Drug design, development and therapy 17 (2023)
Yuanyuan Zhu, Wei Zhang, Jing Chen
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles. Drug design, development and therapy 17 (2023)
Xuedong Yin, Qiaoling Yang, Hongjing Li, Yulin Kang, Zhiling Li
Vancomycin Induced Ferroptosis in Renal Injury Through the Inactivation of Recombinant Glutathione Peroxidase 4 and the Accumulation of Peroxides. Drug design, development and therapy 17 (2023)
Tommy Tsang Cheung, Tu H Mai, Yen Lin Chia, Desmond Y H Yap, Chi-Ho Lee, Cecil Chi-Keung Chen, Ying Huang, Yuwen Jin, James Johnston, Viktoria Werkström, Yuhui Yao, Xiaoyun Ge, Wenying Zheng
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants. Drug design, development and therapy 17 (2023)
Li-Shan Yan, Shuang Cui, Brian Chi-Yan Cheng, Xing-Bin Yin, Yi-Wei Wang, Xin-Yu Qiu, Ci-Ren Nima, Yi Zhang, Shuo-Feng Zhang
Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways. Drug design, development and therapy 17 (2023)
Muhammad Anwar Bashir, Amjad Khan, Sayyed Ibrahim Shah, Majeed Ullah, Fazli Khuda, Muhammad Abbas, Khang Wen Goh, Long Chiau Ming
Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug. Drug design, development and therapy 17 (2023)
Yalan Huang, Yanling Zhang, Yongjun Wu, Qin Xiang, Rong Yu
An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy. Drug design, development and therapy 17 (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
Xuedong Yin, Qiaoling Yang, Hongjing Li, Yulin Kang, Zhiling Li
Vancomycin Induced Ferroptosis in Renal Injury Through the Inactivation of Recombinant Glutathione Peroxidase 4 and the Accumulation of Peroxides. Drug design, development and therapy 17 (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
Kai Dong, Shu-Jing Deng, Bin-Yang He, Zi-Yang Guo, Ze-Lin Guan, Xue Leng, Rui-Rui Ma, Dan-Yang Wang, Jian-Feng Xing, Cui-Yu You
Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema. Drug design, development and therapy 17 (2023)
Zuoya Sun, Zhiyuan Chen, Ruihong Liu, Gang Lu, Zhuo Li, Yi Sun
Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients. Drug design, development and therapy 17 (2023)
Kai Dong, Shu-Jing Deng, Bin-Yang He, Zi-Yang Guo, Ze-Lin Guan, Xue Leng, Rui-Rui Ma, Dan-Yang Wang, Jian-Feng Xing, Cui-Yu You
Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema. Drug design, development and therapy 17 (2023)
Jin-Jin Yang, Lei Lei, Di Qiu, Sai Chen, Li-Ka Xing, Jing-Wei Zhao, Yuan-Yuan Mao, Jian-Jun Yang
Effect of Remimazolam on Postoperative Delirium in Older Adult Patients Undergoing Orthopedic Surgery: A Prospective Randomized Controlled Clinical Trial. Drug design, development and therapy 17 (2023)
Mukaram Amatjan, Na Li, Pengke He, Boheng Zhang, Xianyan Mai, Qianle Jiang, Haochen Xie, Xiaoni Shao
A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Cichorium intybus L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Li-Shan Yan, Shuang Cui, Brian Chi-Yan Cheng, Xing-Bin Yin, Yi-Wei Wang, Xin-Yu Qiu, Ci-Ren Nima, Yi Zhang, Shuo-Feng Zhang
Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways. Drug design, development and therapy 17 (2023)
Qianwen Guo, Xue Li, Wenbin Li, Rong Wang, Anpeng Zhao, Zihan Wang
A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude. Drug design, development and therapy 17 (2023)
Shih-Lung Cheng, Ping-Huai Wang, Cheng-Yu Chang, Hsu-Hui Wang, Chung-Jen Wang, Kuan-Ming Chiu
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19. Drug design, development and therapy 17 (2023)
Jiehan Zhang, Hongrong Li, Dandong Wang, Jiaojiao Gu, Yun-Long Hou, Yi-Ling Wu
Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction. Drug design, development and therapy 17 (2023)
Hasta Handayani Idrus, null Sunarno
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]. Drug design, development and therapy 17 (2023)
Mukaram Amatjan, Na Li, Pengke He, Boheng Zhang, Xianyan Mai, Qianle Jiang, Haochen Xie, Xiaoni Shao
A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Cichorium intybus L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats. Drug design, development and therapy 17 (2023)
Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Yuanyuan Zhu, Wei Zhang, Jing Chen
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles. Drug design, development and therapy 17 (2023)
Yuanyuan Zhu, Wei Zhang, Jing Chen
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles. Drug design, development and therapy 17 (2023)